The invention relates to purinergic receptors so antibodies and related fragments thereof for binding to said receptors to production of said antibodies and fragments and to use of said antibodies and fragments for cancer detection and therapy. In particular the antibodies described bind specifically to non-functional P2X7 receptors by live cells.